Key result
Statin premedication is linked to less radial diastolic strain rate decline after ergonovine provocation.
Why the study?
Persistence of regional diastolic dysfunction after ischemic insult remains debatable and the effect of statin treatment on this dysfunction is unclear.
Does statin premedication prevent persistent regional diastolic dysfunction after ergonovine-provoked myocardial ischemia in patients with variant angina?
Observational (n=31)
Does statin premedication prevent persistent regional diastolic dysfunction after ergonovine-provoked myocardial ischemia in patients with variant angina?
Speckle tracking echocardiography can detect persistent regional diastolic dysfunction following transient ischemia, an effect that appears to be attenuated by prior statin therapy.
Answers are grounded in this paper and cite their sources.
May aid differentiation of ischemic chest pain via STE in VA; leaves open confirmation, statin effects, and clinical adoption pending larger studies.
BACKGROUND: Persistence of regional diastolic dysfunction after ischemic insult remains debatable. With speckle tracking echocardiography (STE), we sought to (1) prove the persistence of regional diastolic dysfunction, (2) assess the feasibility of applying persistent regional diastolic dysfunction to differentiating ischemic and nonischemic chest pain, and finally (3) examine statin effects on postischemic regional diastolic dysfunction. METHODS: Nineteen patients with variant angina (VA) and 12 normal subjects were enrolled. Comprehensive echocardiographic examinations were performed before and 1 day after coronary angiography (CAG) with ergonovine provocation. Radial systolic (rSRsys) and diastolic (rSRdia) strain rates were obtained and averaged using standard segmentation models corresponding to the three major coronary territories assigned. RESULTS: No significant changes in rSRsys and rSRdia values were observed for controls and in rSRsys for VA. However, rSRdia for VA demonstrated a weak, but significant, decrease from -2.25 +/- 0.71/sec to -2.04 +/- 0.71/sec (P = 0.003) 1 day after CAG. However, because of the wide overlap between rSRdia values in normal and ischemic segments for VA patients, predictability of remote ischemia based solely on the rSRdia was limited. Subgroup analysis according to statin prescription showed that statin administration contributed to the elimination of rSRdia reduction (-2.28 +/- 0.84/sec on pre-CAG vs. -2.29 +/- 0.77/sec on post-CAG, P = 0.72 for patients without statin premedication; -2.23 +/- 0.64/sec for pre-CAG vs. -1.88 +/- 0.65/sec for post-CAG, P = 0.002 for those without). Expectedly, rSRsys values showed no significant changes in all situations. CONCLUSIONS: The presence and sustained nature of regional diastolic dysfunction can be demonstrated with STE. Statin minimized the persistence of regional diastolic dysfunction after an acute ischemia. Although the clinical usefulness of rSRdia by STE appears to be limited, its clinical utility requires further consideration, given the brevity of the ischemia provoked during CAG with ergonovine and the protracted regional diastolic dysfunction.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2010) conducted an observational in Variant angina and myocardial ischemia (n=31). Statin premedication vs. No statin premedication was evaluated on Radial diastolic strain rate (rSRdia) 1 day after coronary angiography (p=0.003). Variant angina patients demonstrated a significant decrease in radial diastolic strain rate 1 day after ergonovine provocation, an effect that was minimized by statin premedication.
Synapse has enriched 10 related papers. Consider them for comparative context: